Researchers with non-profit Kaiser Family Foundation have found that more than 25% of those who take insulin and are covered either through a small employer or by individual insurance that meets Affordable Care Act standards would benefit from a $35 monthly cap
While mass compounding of GLP-1s is now illegal, compounders argue that they are personalizing GLP-1s for a smaller subset of patients, which is allowed
This mechanism leads to lower blood sugar levels and modest weight loss as a secondary effect
Subclinical inflammation, telomere shortening, homocysteine, vitamin B6, and mortality: the Ludwigshafen Risk and Cardiovascular Health Study
Itabe, H., Yamaguchi, T., Nimura, S